首页> 外文期刊>Pharmacopsychiatry >Psychiatric disorders biomarker identification: From proteomics to systems biology
【24h】

Psychiatric disorders biomarker identification: From proteomics to systems biology

机译:精神疾病生物标志物鉴定:从蛋白质组学到系统生物学

获取原文
获取原文并翻译 | 示例
           

摘要

The pathobiology of psychiatric disorders remains mostly obscure. Diagnosis is often imprecise and current treatments are empirical and at best symptomatic. The identification of biomarkers can help with developing improved drugs and establishing more precise disease diagnoses. Proteins are prime biomarker candidates, because of the central role they play in both, disease etiology and treatment. Today's high throughput methods are capable to detect potential biomarkers by screening complex proteome mixtures of different disease states. A meaningful interpretation of the candidates is indispensable for deeper insights into affective disorders and requires investigation on multiple levels of the cellular system. Thus a systems biology approach is critical to understand and explain the behavior of biomarker candidates and to make use of them in psychiatry.
机译:精神疾病的病理生物学仍大多不清楚。诊断通常不准确,目前的治疗是经验性的,最好是对症治疗。生物标志物的鉴定可以帮助开发改进的药物和建立更精确的疾病诊断。蛋白质是主要的生物标志物候选物,因为它们在疾病病因学和治疗中均起着核心作用。当今的高通量方法能够通过筛选不同疾病状态的复杂蛋白质组混合物来检测潜在的生物标记。对候选人的有意义的解释对于深入了解情感障碍是必不可少的,并且需要对细胞系统的多个层面进行研究。因此,系统生物学方法对于理解和解释候选生物标志物的行为并在精神病学中加以利用至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号